(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate

Intermediate for Ticagrelor. Ticagrelor(trade name Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor. Ticagrelor is an antagonist of the P2Y12 receptor. Ticagrelor has been approved by US FDA in on July 20, 2011.


Product Name:                  (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate

Synonyms:                         N/A

CAS Number:                     376608-71-8

Molecular Weight:            321.323

Molecular Formula:          C17H17F2NO3

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O[C@H](c1ccccc1)C(=O)O.N[C@@H]1C[C@H]1c1ccc(c(c1)F)F

(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate

  • $138.00
  • Ex Tax: $138.00

Available Options